Drugs / CLS003
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02106260 | Mar → Apr 2014 | common wart | Maruho Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CLS003 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02106260 ↗ |
| Route | Topical | “Topical Ionic Contra-viral Therapy (ICVT) Comprised of CLS003” NCT02106260 ↗ |